Mimedx (MDXG) Cash from Operations (2011 - 2026)

Mimedx has disclosed Cash from Operations across 16 years of filings, most recently posting 1879000.0 for Q1 2026.

• Cash from Operations for Q1 2026 came in at 1879000.0, down 64.54% year-over-year; the trailing twelve-month figure through Mar 2026 was 70583000.0 (up 6.22% YoY), and the FY2025 annual result was 74003000.0, up 10.24% from the prior year.
• Cash from Operations came in at 1879000.0 for Q1 2026 at Mimedx, down from 24956000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 29329000.0 in Q3 2025 to a low of 10223000.0 in Q1 2022.
• The 5-year median for Cash from Operations is 7775000.0 (2023), against an average of 9518411.76.
• Across the five-year window, Cash from Operations slumped 287.93% in 2022 and jumped 1233.79% in 2023, its largest moves.
• Mimedx's Cash from Operations stood at 4297000.0 in 2022, then surged by 138.7% to 10257000.0 in 2023, then jumped by 92.18% to 19712000.0 in 2024, then increased by 26.6% to 24956000.0 in 2025, then slumped by 92.47% to 1879000.0 in 2026.
• The last three Cash from Operations figures came in at 1879000.0 (Q1 2026), 24956000.0 (Q4 2025), and 29329000.0 (Q3 2025), per Business Quant data.